Construction of a cohort of drug-susceptible tuberculosis patients and identification of RNA signatures to predict treatment outcomes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200065862

Enrollment

Unknown

Registered

2022-11-17

Start date

2022-11-21

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

observation group:none

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old; 2. Newly diagnosed pulmonary TB, confirmed by sputum culture.

Exclusion criteria

Exclusion criteria: 1. Poor treatment compliance; 2. Rheumatic diseases, severe cardiovascular disease, malignant tumor, HIV, mental illness.

Design outcomes

Primary

Measure	Time frame
differentially expressed genes;	—

Countries

China

Contacts

Public ContactHongjuan Qin

The Third People's Hospital of Shenzhen

qinhj2013@163.com+86 136 2285 7917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026